Back to search

Article

The evolution of medulloblastoma therapy to personalized medicine

2017-04-13

Abstract excerpt

Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signaling pathway (SHH)-activated and tumor suppressor protein p53 (TP53)-mutant, SHH-activated and TP53-wildtype, and non-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f4ceebc-1660-5166-bb57-97e0c95711f8
DOI
10.12688/f1000research.10859.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The evolution of medulloblastoma therapy to personalized medicineDOI 10.12688/f1000research.10859.1
Select a neighboring publication to make it the new centre.